Motley Fool Premium
  1. Stocks
    2. /
  2. Smith & Nephew plc (LSE: SN.)
    3. /

LSE:SN. (Smith & Nephew plc)

About SN.

Medical devices group Smith & Nephew makes nearly half of its revenues through its orthopaedics division, which manufactures knee joints, braces and other supports. Established in 1931, the group now has interests all over the world.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Smith & Nephew plc (LSE: SN.) Latest News

Investing Articles

Why Smith & Nephew plc’s Latest Failure Should Worry AstraZeneca plc And GlaxoSmithKline plc

| Royston Wild

Royston Wild explains how Smith and Nephew plc (LON: SN)'s latest testing woes underlines the precarious nature of drugs testing

Read more »

Investing Articles

3 Neil Woodford Plays On Ageing Populations: AstraZeneca plc, Smith & Nephew plc And Capita PLC

| G A Chester

AstraZeneca plc (LON:AZN), Smith & Nephew plc (LON:SN) and Capita PLC (LON:CPI) could super-charge your portfolio.

Read more »

Investing Articles

Are AstraZeneca plc & GlaxoSmithKline plc A Sound Investment Right Now?

| Alessandro Pasetti

AstraZeneca plc (LON:AZN) and GlaxoSmithKline plc (LON:GSK) could outperform companies operating in more troubled sectors, and for different reasons, argues…

Read more »

Investing Articles

How Regulatory Wrath Has Hammered Investors In BP plc, HSBC Holdings plc And Smith & Nephew

| Harvey Jones

BP plc (LON: BP), HSBC Holdings plc (LON: HSBA) and Smith & Nephew plc (LON: SN) have all incurred costly…

Read more »

Investing Articles

3 FTSE 100 Stocks Up On M&A Talk: Vodafone Group plc, Smith & Nephew plc And AstraZeneca plc

| Alessandro Pasetti

Vodafone Group plc (LON:VOD), Smith & Nephew plc (LON:SN) and AstraZeneca plc (LON:AZN) are under the spotlight.

Read more »

Investing Articles

Neil Woodford’s Portfolio: Downside For BT Group plc, Centrica plc, Rolls-Royce Holdings plc, Smith & Nephew plc & G4S plc

| Alessandro Pasetti

Will Neil Woodford trim exposure to BT Group plc (LON:BT-A), Rolls-Royce Holdings plc (LON:RR), Centrica plc (LON:CNA), Smith & Nephew…

Read more »

Investing Articles

Is AstraZeneca plc’s Latest Director Deal A Game-Changer?

| Peter Stephens

With AstraZeneca plc (LON:AZN)'s CEO buying shares this week, is it a significant event for investors?

Read more »

Investing Articles

Is It Time To Cash In On Takeover Target Smith & Nephew plc?

| Alessandro Pasetti

Smith & Nephew (LON:SN) is still an appealing investment, argues this Fool.

Read more »

Company Comment

Transcript: Should You Buy Shares In TSB?

| Owain Bennallack

Owain Bennallack debates the pros and cons of investing in the TSB spin-off with Nate Weisshaar and Mark Rogers.

Read more »

Money Talk Podcast Archives

Should You Buy Shares In TSB?

| Owain Bennallack

Owain Bennallack debates the pros and cons of investing in the TSB spin-off with Nate Weisshaar and Mark Rogers.

Read more »

Investing Articles

Could It Be Time For A Takeover Of Smith & Nephew plc?

| Alessandro Pasetti

Smith & Nephew plc (LON:SN) bears the hallmarks of a take-private deal.

Read more »

Investing Articles

Smith & Nephew plc: Shining Bright In A Greying World

| The Motley Fool Staff

Smith & Nephew plc (LON:SN) can benefit from an ageing population.

Read more »